×
About 18 results

ALLMedicine™ Autoimmune Gastrointestinal Dysmotility Center

Research & Reviews  9 results

Intravenous immunoglobulin in drug and device refractory patients with the symptoms of ...
https://doi.org/10.1111/nmo.13256
Neurogastroenterology and Motility : the Official Journal... Ashat M, Lewis A et. al.

Dec 5th, 2017 - Gastroparesis is a complex clinical entity; many aspects of which remain unknown. Although most patients have idiopathic, diabetic, or postsurgical gastroparesis, many are thought to have measurable neuromuscular abnormalities. Immunotherapy has r...

Autoimmune gastrointestinal dysmotility due to small cell lung cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623317
BMJ Case Reports; Lipowska AM, Micic D et. al.

Aug 12th, 2017 - The diagnosis of autoimmune gastrointestinal dysmotility requires a high level of clinical suspicion when standard work-up is unrevealing. We report the case of a 56-year-old male patient with history of tobacco use and a subacute presentation of ...

Autoimmune gastrointestinal dysmotility
https://rarediseases.info.nih.gov/diseases/12063/autoimmune-gastrointestinal-dysmotility

Jul 26th, 2017 - Autoimmune gastrointestinal dysmotility (AGID) is a type of dysautonomia that may be idiopathic (cause unknown) or associated with cancer elsewhere in the body, most commonly small cell lung cancer.[1] Signs and symptoms may include early satiety ...

Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149849
Neurogastroenterology and Motility : the Official Journal... Flanagan EP, Saito YA et. al.

Jul 21st, 2014 - Chronic gastrointestinal dysmotility greatly impacts the quality of life. Treatment options are limited and generally symptomatic. Neural autoimmunity is an under-recognized etiology. We evaluated immunotherapy as an aid to diagnosing autoimmune g...

Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535544
Neurogastroenterology and Motility : the Official Journal... Meeusen JW, Haselkorn KE et. al.

Oct 17th, 2012 - Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia. The only proven effector to date is IgG specific for ganglionic nicotinic-acetylcholine receptors containing α3 subunits [α3*- nicotinic acetylcholine receptor (nACh...

see more →

Clinicaltrials.gov  9 results

Intravenous immunoglobulin in drug and device refractory patients with the symptoms of ...
https://doi.org/10.1111/nmo.13256
Neurogastroenterology and Motility : the Official Journal... Ashat M, Lewis A et. al.

Dec 5th, 2017 - Gastroparesis is a complex clinical entity; many aspects of which remain unknown. Although most patients have idiopathic, diabetic, or postsurgical gastroparesis, many are thought to have measurable neuromuscular abnormalities. Immunotherapy has r...

Autoimmune gastrointestinal dysmotility due to small cell lung cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623317
BMJ Case Reports; Lipowska AM, Micic D et. al.

Aug 12th, 2017 - The diagnosis of autoimmune gastrointestinal dysmotility requires a high level of clinical suspicion when standard work-up is unrevealing. We report the case of a 56-year-old male patient with history of tobacco use and a subacute presentation of ...

Autoimmune gastrointestinal dysmotility
https://rarediseases.info.nih.gov/diseases/12063/autoimmune-gastrointestinal-dysmotility

Jul 26th, 2017 - Autoimmune gastrointestinal dysmotility (AGID) is a type of dysautonomia that may be idiopathic (cause unknown) or associated with cancer elsewhere in the body, most commonly small cell lung cancer.[1] Signs and symptoms may include early satiety ...

Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149849
Neurogastroenterology and Motility : the Official Journal... Flanagan EP, Saito YA et. al.

Jul 21st, 2014 - Chronic gastrointestinal dysmotility greatly impacts the quality of life. Treatment options are limited and generally symptomatic. Neural autoimmunity is an under-recognized etiology. We evaluated immunotherapy as an aid to diagnosing autoimmune g...

Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535544
Neurogastroenterology and Motility : the Official Journal... Meeusen JW, Haselkorn KE et. al.

Oct 17th, 2012 - Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia. The only proven effector to date is IgG specific for ganglionic nicotinic-acetylcholine receptors containing α3 subunits [α3*- nicotinic acetylcholine receptor (nACh...

see more →